Albuterol Sulfate Inhalant
Product Images NDC 69097-142

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 69097-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (234fba93 8b9b 46de 8d61 088bd0a30b98 01)

Chemical structure diagram of albuterol sulfate showing the molecular arrangement and functional groups including hydroxyl and amine groups, consistent with the active ingredient albuterol sulfate in the inhalant dosage form.*

FDA Label Image

Image (234fba93 8b9b 46de 8d61 088bd0a30b98 02)

A line graph titled 'FEV1 as Percent Change from Predose in a Large 12-Week Clinical Trial' showing percent change in FEV1 over time (hours) up to 6 hours. The graph compares three groups: Albuterol sulfate inhalation aerosol (2 puffs, 4 times daily), CFC 11/12 Albuterol (2 puffs, 4 times daily), and HFA-134a Placebo (2 puffs, 4 times daily). Percent change peaks near 25% for both albuterol groups shortly after dosing and decreases over time, while the placebo group shows a smaller and steady increase below 10%.*

FDA Label Image

Image (234fba93 8b9b 46de 8d61 088bd0a30b98 03)

A text panel providing a website URL for more information or a video demonstration on how to use the product, www.ciplaalbuterolhfa.com, along with a phone number, 1-866-604-3268, and a QR code for scanning.*

FDA Label Image

Image (234fba93 8b9b 46de 8d61 088bd0a30b98 04)

Instructional line drawing of an albuterol sulfate inhalant device showing a side view and a top view. The side view labels the dose indicator, canister, actuator, mouthpiece, and cap. The top view details the dose indicator display window, pointer, and press area, illustrating how to read and operate the dose indicator of the inhaler.*

FDA Label Image

Image (234fba93 8b9b 46de 8d61 088bd0a30b98 05)

An illustration showing the top view of the dose indicator on an ALBUTEROL SULFATE 90 ug/inh inhalant. The dial shows dose counts marked at intervals including 0, 20, and 40, used for tracking remaining doses in the inhaler device.*

FDA Label Image

Image (234fba93 8b9b 46de 8d61 088bd0a30b98 06)

An instructional illustration showing a hand holding an inhalant device for albuterol sulfate. The diagram highlights the upright position of the device with arrows pointing to the mouthpiece and cap, which is being removed or placed on the inhaler.*

FDA Label Image

Image (234fba93 8b9b 46de 8d61 088bd0a30b98 07)

An instructional line drawing showing a person using an inhalant device, specifically demonstrating inhalation technique for a respiratory drug such as albuterol sulfate inhalant. The image highlights the proper positioning of the mouth and inhaler during use.*

FDA Label Image

Image (234fba93 8b9b 46de 8d61 088bd0a30b98 08)

An instructional illustration showing a hand holding an inhaler being rinsed under running water from a faucet. Also depicted are the opened inhaler canister and the inhaler cap placed on a surface, demonstrating cleaning steps for the respiratory inhalant device.*

FDA Label Image

Image (234fba93 8b9b 46de 8d61 088bd0a30b98 09)

Illustration showing proper and improper use of an albuterol sulfate inhalant. The top image depicts a hand pressing the inhaler correctly with an unobstructed spray labeled "not blocked." The bottom image shows a blocked spray with a reduced mist, labeled "blocked." The diagram instructs users on effective inhalation technique.*

FDA Label Image

Image (234fba93 8b9b 46de 8d61 088bd0a30b98 10)

An instructional illustration labeled 'Figure G' showing an inhaler device with its cap removed, the inhaler canister separated, and an open window with a crescent moon visible outside. The image likely relates to the usage or storage of albuterol sulfate inhalant.*

FDA Label Image

Cipla-container-label (Cipla Container Label)

Label for Albuterol Sulfate Inhalation Aerosol, 90 mcg per actuation, by Cipla USA Inc. The label states it is for oral inhalation with enclosed actuator only. It contains 200 metered inhalations with a net content of 6.7 g. The label includes storage instructions, manufacturer details, and a barcode.*

FDA Label Image

Carton-label-cipla (Carton Label Cipla)

Packaging label for Albuterol Sulfate Inhalation Aerosol 90 mcg, from Cipla USA Inc. The label includes dosing information with a dose indicator, states it is for oral inhalation with enclosed actuator only, and contains 200 metered inhalations. It highlights that the product contains no chlorofluorocarbons (CFCs) and provides warnings, storage instructions, and manufacturer details. The label also features areas designated for batch overprinting including GTIN, serial number, expiry, and lot information.*

FDA Label Image

Container Label Fall River (234fba93 8b9b 46de 8d61 088bd0a30b98 13)

Label for ALBUTEROL SULFATE inhalation aerosol 90 mcg metered dose inhaler by Cipla USA Inc. The label shows NDC 69097-142-60, 200 metered inhalations, net contents 6.7 g, and includes dosing and storage information. It also features a dose indicator and administration instructions for oral inhalation.*

FDA Label Image

Carton-label-fall-river (Carton Label Fall River)

Packaging label for Albuterol Sulfate Inhalation Aerosol, 90 mcg per actuation, by Cipla USA Inc. The label indicates 200 metered inhalations per canister with a dose indicator. It specifies the product is for oral inhalation only and contains no chlorofluorocarbons (CFCs). Various warnings and usage instructions are provided, along with the product NDC 69097-142-60.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.